Program Schedule

The following presentations will be available on-demand from February 18 – February 27, plus 30 days post-meeting (until March 29, 2021):

Tricks for Tics: Can We Predict a Fix?
Barbara Coffey, MD, MS 
Psychopharmacologic treatment of tic disorders and Tourette’s disorder is often complicated, at least in part because the vast majority of children and adolescents referred for medication evaluation have complicated phenotypes. Additionally, to this day there are only three formally approved pharmacological treatments for Tourette’s disorder in the United States, and all are neuroleptics. Results from recent clinical trials testing have been disappointing. Taken together, child and adolescent psychiatrists are faced with limited treatment options, and even more limited data regarding predictors and moderators of treatment response. Data on those few predictors that have been elicited are derived from cognitive-behavioral treatment studies. Guidelines for incorporation of extant data on treatment response and recommendations for clinical psychopharmacological algorithms will be discussed.

Harnessing Pharmacogenetic Testing to Optimize Treatment
Laura Ramsey, PhD
Optimizing dosing through pharmacogenetics. This presentation will discuss the evidence behind pharmacogenetically-guided dosing and how to implement it.

Management of Acute Agitation
Vera Feuer, MD
Discussion of an etiology-driven algorithm supporting clinicians with decision making in managing pediatric agitation in emergency settings, including rapid history taking, utilizing de-escalation and environmental approaches and incorporating developmental and communication considerations.

SSRIs and Beyond: Medication Management to Help Kids Talk Back to OCD
Katherine Fitzgerald, MD

Pharmacologic Interventions for Children and Adolescents with Early Psychosis: Do's, Don'ts, and What's New in the Field
Rhoshel K. Lenroot, MD
This talk will discuss how pharmacology fits into optimal care for youth with early psychosis, and what is known about how to tailor this for children and adolescents.

Can We Re-Regulate Dysregulated Children With Medication?
Gabrielle A. Carlson, MD
The talk will address the fact that dysregulation is transdiagnostic. Some success can be derived from treating the underlying disorder, but we have more trouble with what is left over if we can only partially treat it.

Neuromodulation in Children and Adolescents
Paul E. Croarkin, DO, MS
Interventional psychiatry approaches such as noninvasive brain stimulation and ketamine infusions are increasingly pondered as treatments for youth in the era of precision medicine. Although this evidence base is gradually coming of age there are many substantial knowledge gaps to consider. Noninvasive brain stimulation modalities appear to have a favorable side effect profile and may have utility in the treatment of mood and neurodevelopmental disorders.

Selecting the 'Right' Medication in Pediatric Anxiety Disorders
Jeffrey R. Strawn, MD
This presentation will focus on which antidepressants may be most effective in pediatric anxiety disorders and how they differ in terms of tolerability. Data related will be presented that help clinicians identify when to sequence treatments and when to start with medication or psychotherapy in treating youth with anxiety disorders. Recent studies that have examined comparative tolerability will also be reviewed.


The following is the schedule of Virtual Live Sessions February 26 – February 27:

Day/Time

Session

Speaker(s)

Friday, February 26

   

4:00 pm-5:00 pm ET

Q&A Panel Session

  • Jeffrey R. Strawn, MD
  • Katherine Fitzgerald, MD
  • Paul E. Croarkin, DO, MS
  • Barbara Coffey, MD, MS
  • Gabrielle A. Carlson, MD, Moderator

5:15 pm-6:15 pm ET

Small Group Case Discussions*

(see list below for topics)

6:30 pm-7:30 pm ET

Small Group Case Discussions*

(see list below for topics)

 

 

 

Saturday, February 27

 

 

12:00 pm-1:00 pm ET

Q&A Panel Session

  • Gabrielle A. Carlson, MD
  • Laura Ramsey, PhD
  • Vera Feuer, MD
  • Rhoshel K. Lenroot, MD
  • Jeffrey R. Strawn, MD, Moderator

1:15 pm-2:15 pm ET

Small Group Case Discussions*

(see list below for topics)

2:30 pm-3:30 pm ET

Small Group Case Discussions*

(see list below for topics)


*For the Small Group Case Discussions, all attendees are able to select participating in two (2) sessions over both days (NOT 2 sessions per day). Session sign-up is on a first-come first served basis, so be sure to register early to claim your two spots before they fill up!

Here are the Small Group Case Discussions to choose from for each of the (4) time slots:

Topic

Presenter

Tics

Barbara Coffey, MD, MS

Pharmacogenetics

Laura Ramsey, PhD 

Agitation and Delirium

Vera Feuer, MD 

OCD

Katherine Fitzgerald, MD 

Psychosis

Rhoshel K. Lenroot, MD

Dysregulation

Gabrielle A. Carlson, MD 

TMS

Paul E. Croarkin, DO, MS 

Precision Dosing

Jeffrey R. Strawn, MD